Highlight selection of radiochemistry and radiopharmacy developments by editorial board

S Spreckelmeyer; J Dasilva; C Decristoforo; R H Mach; J Passchier; G Carlucci; M Al Qhatani; A Duatti; B T Cornelissen; J Engle; A Denkova; J J M A Hendrikx; Y Seimbille; X Yang; H Jia; M-R Zhang; M Yang; L Perk; P Caravan; P Laverman; Z Cheng; C Hoehr; T Sakr; J R Zeevaart

doi:10.1186/s41181-025-00335-w

Highlight selection of radiochemistry and radiopharmacy developments by editorial board

S Spreckelmeyer
, J Dasilva
, C Decristoforo
, R H Mach
, J Passchier
, G Carlucci
, M Al Qhatani
, A Duatti
, B T Cornelissen
, J Engle
, A Denkova
, J J M A Hendrikx
, Y Seimbille
, X Yang
, H Jia
, M-R Zhang
, M Yang
, L Perk
, P Caravan
, P Laverman

Z Cheng, C Hoehr, T Sakr, J R Zeevaart

Radiology & Nuclear Medicine

Berlin Institute of Health
University of Montreal
Innsbruck Medical University
University of Pennsylvania
University of California
King Faisal Specialist Hospital and Research Center
University of Ferrara
University of Wisconsin
Amsterdam
Beijing Normal University
National Institutes for Quantum and Radiological Science and Technology
Radboud University Medical Center
Harvard University
TRIUMF
Egyptian Atomic Energy Authority
Necsa

Research output: Contribution to journal › Review article › Academic › peer-review

1 Citation (Scopus)

24 Downloads (Pure)

Abstract

Background:

The Editorial Board of EJNMMI Radiopharmacy and Chemistry releases a biannual highlight commentary to update the readership on trends in the field of radiopharmaceutical development and application of radiopharmaceuticals.

Main body:

This selection of highlights provides commentary on 24 different topics selected by each co-authoring Editorial Board member addressing a variety of aspects ranging from novel radiochemistry to first-in-human application of novel radiopharmaceuticals.

Conclusion:

Trends in radiochemistry and radiopharmacy are highlighted. Hot topics cover the entire scope of EJNMMI Radiopharmacy and Chemistry, demonstrating the progress in the research field in many aspects.

Original language	English
Article number	13
Pages (from-to)	13
Journal	EJNMMI Radiopharmacy and Chemistry
Volume	10
Issue number	1
DOIs	https://doi.org/10.1186/s41181-025-00335-w
Publication status	Published - 25 Mar 2025

Bibliographical note

Access to Document

10.1186/s41181-025-00335-wLicence: CC BY-NC-ND

Highlight selection of radiochemistry and radiopharmacy developments by editorial boardFinal published version, 1.6 MBLicence: CC BY-NC-ND

Cite this

Spreckelmeyer, S., Dasilva, J., Decristoforo, C., Mach, R. H., Passchier, J., Carlucci, G., Qhatani, M. A., Duatti, A., Cornelissen, B. T., Engle, J., Denkova, A., Hendrikx, J. J. M. A., Seimbille, Y., Yang, X., Jia, H., Zhang, M.-R., Yang, M., Perk, L., Caravan, P., ... Zeevaart, J. R. (2025). Highlight selection of radiochemistry and radiopharmacy developments by editorial board. EJNMMI Radiopharmacy and Chemistry, 10(1), 13. Article 13. https://doi.org/10.1186/s41181-025-00335-w

@article{13a4cf7c0c564796a6183ada975f2195,

title = "Highlight selection of radiochemistry and radiopharmacy developments by editorial board",

abstract = "Background: The Editorial Board of EJNMMI Radiopharmacy and Chemistry releases a biannual highlight commentary to update the readership on trends in the field of radiopharmaceutical development and application of radiopharmaceuticals. Main body: This selection of highlights provides commentary on 24 different topics selected by each co-authoring Editorial Board member addressing a variety of aspects ranging from novel radiochemistry to first-in-human application of novel radiopharmaceuticals. Conclusion: Trends in radiochemistry and radiopharmacy are highlighted. Hot topics cover the entire scope of EJNMMI Radiopharmacy and Chemistry, demonstrating the progress in the research field in many aspects.",

author = "S Spreckelmeyer and J Dasilva and C Decristoforo and Mach, \{R H\} and J Passchier and G Carlucci and Qhatani, \{M Al\} and A Duatti and Cornelissen, \{B T\} and J Engle and A Denkova and Hendrikx, \{J J M A\} and Y Seimbille and X Yang and H Jia and M-R Zhang and M Yang and L Perk and P Caravan and P Laverman and Z Cheng and C Hoehr and T Sakr and Zeevaart, \{J R\}",

note = "{\textcopyright} The Author(s) 2025.",

year = "2025",

month = mar,

day = "25",

doi = "10.1186/s41181-025-00335-w",

language = "English",

volume = "10",

pages = "13",

journal = "EJNMMI Radiopharmacy and Chemistry",

issn = "2365-421X",

publisher = "Springer Science+Business Media",

number = "1",

}

Spreckelmeyer, S, Dasilva, J, Decristoforo, C, Mach, RH, Passchier, J, Carlucci, G, Qhatani, MA, Duatti, A, Cornelissen, BT, Engle, J, Denkova, A, Hendrikx, JJMA, Seimbille, Y, Yang, X, Jia, H, Zhang, M-R, Yang, M, Perk, L, Caravan, P, Laverman, P, Cheng, Z, Hoehr, C, Sakr, T & Zeevaart, JR 2025, 'Highlight selection of radiochemistry and radiopharmacy developments by editorial board', EJNMMI Radiopharmacy and Chemistry, vol. 10, no. 1, 13, pp. 13. https://doi.org/10.1186/s41181-025-00335-w

TY - JOUR

T1 - Highlight selection of radiochemistry and radiopharmacy developments by editorial board

AU - Spreckelmeyer, S

AU - Dasilva, J

AU - Decristoforo, C

AU - Mach, R H

AU - Passchier, J

AU - Carlucci, G

AU - Qhatani, M Al

AU - Duatti, A

AU - Cornelissen, B T

AU - Engle, J

AU - Denkova, A

AU - Hendrikx, J J M A

AU - Seimbille, Y

AU - Yang, X

AU - Jia, H

AU - Zhang, M-R

AU - Yang, M

AU - Perk, L

AU - Caravan, P

AU - Laverman, P

AU - Cheng, Z

AU - Hoehr, C

AU - Sakr, T

AU - Zeevaart, J R

PY - 2025/3/25

Y1 - 2025/3/25

N2 - Background: The Editorial Board of EJNMMI Radiopharmacy and Chemistry releases a biannual highlight commentary to update the readership on trends in the field of radiopharmaceutical development and application of radiopharmaceuticals. Main body: This selection of highlights provides commentary on 24 different topics selected by each co-authoring Editorial Board member addressing a variety of aspects ranging from novel radiochemistry to first-in-human application of novel radiopharmaceuticals. Conclusion: Trends in radiochemistry and radiopharmacy are highlighted. Hot topics cover the entire scope of EJNMMI Radiopharmacy and Chemistry, demonstrating the progress in the research field in many aspects.

AB - Background: The Editorial Board of EJNMMI Radiopharmacy and Chemistry releases a biannual highlight commentary to update the readership on trends in the field of radiopharmaceutical development and application of radiopharmaceuticals. Main body: This selection of highlights provides commentary on 24 different topics selected by each co-authoring Editorial Board member addressing a variety of aspects ranging from novel radiochemistry to first-in-human application of novel radiopharmaceuticals. Conclusion: Trends in radiochemistry and radiopharmacy are highlighted. Hot topics cover the entire scope of EJNMMI Radiopharmacy and Chemistry, demonstrating the progress in the research field in many aspects.

UR - https://www.scopus.com/pages/publications/105001025788

U2 - 10.1186/s41181-025-00335-w

DO - 10.1186/s41181-025-00335-w

M3 - Review article

C2 - 40131608

SN - 2365-421X

VL - 10

SP - 13

JO - EJNMMI Radiopharmacy and Chemistry

JF - EJNMMI Radiopharmacy and Chemistry

IS - 1

M1 - 13

ER -

Highlight selection of radiochemistry and radiopharmacy developments by editorial board

Abstract

Bibliographical note

Access to Document

Other files and links

Cite this